A new review has suggested mixing classic psychedelics with lithium could pose a heightened risk of seizures.
An international patent application has been filed by Mindset Pharma Inc.
UK scientists are to research the potential of psilocybin to boost the effects of talking therapies for people with an end-of-life diagnosis.
The UK not-for-profit organisation, Heroic Hearts, is to undertake groundbreaking research exploring the potential of psilocybin for treating traumatic brain injury in veterans.
A quantum drug development programme has been launched by psychedelic healthcare company PsiloThera.